Biocomposites adds proprietary NanoBone® technology to its portfolio through the acquisition of Artoss GmbH
NanoBone® technology complements Biocomposites’ absorbable bone regeneration products
Artoss to benefit from Biocomposites established, global distribution network
Keele, UK, 6 June 2023 – Biocomposites, an international medical devices company that engineers, manufactures and markets world leading products for regenerating bone and managing infection in bone and soft tissue, today announces the acquisition of Artoss GmbH (Artoss), a specialist manufacturer of innovative bone graft substitutes for use in orthopaedics, spine, foot and ankle, and dentistry.
